These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 27302574

  • 1. Characterization of different CTC subpopulations in non-small cell lung cancer.
    Hanssen A, Wagner J, Gorges TM, Taenzer A, Uzunoglu FG, Driemel C, Stoecklein NH, Knoefel WT, Angenendt S, Hauch S, Atanackovic D, Loges S, Riethdorf S, Pantel K, Wikman H.
    Sci Rep; 2016 Jun 15; 6():28010. PubMed ID: 27302574
    [Abstract] [Full Text] [Related]

  • 2. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
    Scharpenseel H, Hanssen A, Loges S, Mohme M, Bernreuther C, Peine S, Lamszus K, Goy Y, Petersen C, Westphal M, Glatzel M, Riethdorf S, Pantel K, Wikman H.
    Sci Rep; 2019 May 15; 9(1):7406. PubMed ID: 31092882
    [Abstract] [Full Text] [Related]

  • 3. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
    Beck TN, Boumber YA, Aggarwal C, Pei J, Thrash-Bingham C, Fittipaldi P, Vlasenkova R, Rao C, Borghaei H, Cristofanilli M, Mehra R, Serebriiskii I, Alpaugh RK.
    BMC Cancer; 2019 Jun 19; 19(1):603. PubMed ID: 31215484
    [Abstract] [Full Text] [Related]

  • 4. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, Ranson M, Blackhall FH, Dive C.
    J Thorac Oncol; 2012 Feb 19; 7(2):306-15. PubMed ID: 22173704
    [Abstract] [Full Text] [Related]

  • 5. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L, Peng M, Li N, Song Q, Yao Y, Xu B, Liu H, Ruan P.
    Sci Rep; 2018 Jan 19; 8(1):1188. PubMed ID: 29352248
    [Abstract] [Full Text] [Related]

  • 6. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S, Katagiri N, Namba Y, Tulafu M, Nagahama K, Kadoya K, Takamochi K, Oh S, Suzuki K, Sakurai F, Mizuguchi H, Urata Y, Takahashi K.
    Oncotarget; 2017 May 23; 8(21):34884-34895. PubMed ID: 28432274
    [Abstract] [Full Text] [Related]

  • 7. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
    Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, Takahashi T, Murakami H, Nakamura Y, Tsuya A, Shukuya T, Ono A, Akamatsu H, Watanabe R, Ono S, Mori K, Kanbara H, Yamaguchi K, Tanaka T, Matsunaga T, Yamamoto N.
    PLoS One; 2013 May 23; 8(6):e67466. PubMed ID: 23840710
    [Abstract] [Full Text] [Related]

  • 8. Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.
    Mariscal J, Alonso-Nocelo M, Muinelo-Romay L, Barbazan J, Vieito M, Abalo A, Gomez-Tato A, Maria de Los Angeles CC, Garcia-Caballero T, Rodriguez C, Brozos E, Baron F, Lopez-Lopez R, Abal M.
    Sci Rep; 2016 Nov 30; 6():37820. PubMed ID: 27901069
    [Abstract] [Full Text] [Related]

  • 9. A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.
    Lindsay CR, Faugeroux V, Michiels S, Pailler E, Facchinetti F, Ou D, Bluthgen MV, Pannet C, Ngo-Camus M, Bescher G, Caramella C, Billiot F, Remon J, Planchard D, Soria JC, Besse B, Farace F.
    Ann Oncol; 2017 Jul 01; 28(7):1523-1531. PubMed ID: 28633480
    [Abstract] [Full Text] [Related]

  • 10. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.
    Kasimir-Bauer S, Hoffmann O, Wallwiener D, Kimmig R, Fehm T.
    Breast Cancer Res; 2012 Jan 20; 14(1):R15. PubMed ID: 22264265
    [Abstract] [Full Text] [Related]

  • 11. Single tube liquid biopsy for advanced non-small cell lung cancer.
    de Wit S, Rossi E, Weber S, Tamminga M, Manicone M, Swennenhuis JF, Groothuis-Oudshoorn CGM, Vidotto R, Facchinetti A, Zeune LL, Schuuring E, Zamarchi R, Hiltermann TJN, Speicher MR, Heitzer E, Terstappen LWMM, Groen HJM.
    Int J Cancer; 2019 Jun 15; 144(12):3127-3137. PubMed ID: 30536653
    [Abstract] [Full Text] [Related]

  • 12. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W, Kraan J, Mostert B, Timmermans MM, Charehbili A, Smit VT, Kroep JR, Nortier JW, van de Ven S, Heijns JB, Kessels LW, van Laarhoven HW, Bos MM, van de Velde CJ, Gratama JW, Sieuwerts AM, Martens JW, Foekens JA, Sleijfer S.
    Mol Cancer Ther; 2015 Mar 15; 14(3):821-7. PubMed ID: 25552367
    [Abstract] [Full Text] [Related]

  • 13. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
    Ilie M, Szafer-Glusman E, Hofman V, Long-Mira E, Suttmann R, Darbonne W, Butori C, Lalvée S, Fayada J, Selva E, Yu W, Marquette CH, Shames DS, Punnoose E, Hofman P.
    Oncotarget; 2017 Apr 18; 8(16):26112-26121. PubMed ID: 28212540
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.
    Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, Hughes BG, Hicks RJ, Hampton GM, Amler LC, Pirzkall A, Lackner MR.
    Clin Cancer Res; 2012 Apr 15; 18(8):2391-401. PubMed ID: 22492982
    [Abstract] [Full Text] [Related]

  • 15. Detection of circulating tumor cells in patients with lung cancer using a rare cell sorter: a pilot study.
    Sugai K, Mori T, Bilal T, Furukawa A, Sekine Y, Kobayashi N, Kikuchi S, Goto Y, Ichimura H, Masuda T, Arai F, Sato Y, Matsusaka S.
    BMC Cancer; 2024 Oct 18; 24(1):1291. PubMed ID: 39425044
    [Abstract] [Full Text] [Related]

  • 16. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.
    Tada H, Takahashi H, Kawabata-Iwakawa R, Nagata Y, Uchida M, Shino M, Ida S, Mito I, Matsuyama T, Chikamatsu K.
    Sci Rep; 2020 Dec 09; 10(1):21573. PubMed ID: 33299117
    [Abstract] [Full Text] [Related]

  • 17. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF.
    Breast Cancer Res; 2008 Dec 09; 10(4):R69. PubMed ID: 18687126
    [Abstract] [Full Text] [Related]

  • 18. Differential expression and activation of epidermal growth factor receptor 1 (EGFR1), ERK, AKT, STAT3, and TWIST1 in nonsmall cell lung cancer (NSCLC).
    Gorgisen G, Ozes D, Pehlivanoglu S, Erdogan A, Dertsiz L, Ozbilim G, Ozbudak IH, Savas B, Ozes ON.
    Exp Lung Res; 2013 Nov 09; 39(9):387-98. PubMed ID: 24117170
    [Abstract] [Full Text] [Related]

  • 19. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
    Ishii H, Azuma K, Sakai K, Kawahara A, Yamada K, Tokito T, Okamoto I, Nishio K, Hoshino T.
    Oncotarget; 2015 Oct 13; 6(31):30850-8. PubMed ID: 26334838
    [Abstract] [Full Text] [Related]

  • 20. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C.
    Acta Oncol; 2011 Jun 13; 50(5):700-10. PubMed ID: 21261508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.